Predicting the Contribution of Rat Cytochrome P-450 3A1, 3A2 and Human Cytochrome P-450 3A4, 3A5 to Territrem a 4beta-C Hydroxylation Using the Relative Activity Factor

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Toxicology and Environmental Health, Part A

• Publication date

  2008-09-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/15287390802240942PMID 18800290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Territrems B and C metabolism in human liver microsomes: major role of CYP3A4 and CYP3A5.

  2006cited by this paper
• Cytochrome P-4503A1 Catalyzes the Formation of MA 1 from Territrem a in Liver Microsomes of 7-Week-Old Female Wistar Rats

  2003cited by this paper
• Role of Human Hepatic Cytochrome P-450S in Territrem a Metabolism

  2003cited by this paper
• Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification.

  2003cited by this paper
• METABOLISM OF TERRITREM A IN LIVER MICROSOMES FROM MALE WISTAR RATS: 3. CYTOCHROME P-450 ISOFORMS CATALYZING TRA METABOLISM

  2002cited by this paper
• In Vitro/in Vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans

  2001cited by this paper
• METABOLISM OF TERRITREM A BY LIVER MICROSOMES OF WISTAR RATS: IDENTIFICATION OF THE METABOLITES AND THEIR METABOLIC SEQUENCE

  2001cited by this paper
• Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.

  2001cited by this paper
• Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes.

  2000cited by this paper
• Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism.

  2000cited by this paper
• Territrem B, a Tremorgenic Mycotoxin That Inhibits Acetylcholinesterase with a Noncovalent yet Irreversible Binding Mechanism*

  1999cited by this paper
• Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man.

  1998cited by this paper
• Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

  1998cited by this paper
• Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes.

  1997cited by this paper
• Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

  1997cited by this paper
• Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research

  1995cited by this paper
• Territrems, tremorgenic mycotoxins isolated from Aspergillus terreus

  1994cited by this paper
• Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.

  1993cited by this paper
• Isolation, chemical structure, acute toxicity, and some physicochemical properties of territrem B' from Aspergillus terreus

  1985cited by this paper
• Isolation, chemical structure, acute toxicity, and some physicochemical properties of territrem C from Aspergillus terreus

  1984cited by this paper
• Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes.

  1983cited by this paper
• Solvent systems for improved isolation and separation of territrems A and B

  1982cited by this paper
• Territrems, tremorgenic mycotoxins of Aspergillus terreus

  1979cited by this paper
• Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes.

  1970cited by this paper
• Evidence for biochemically different types of vesicles in the hepatic microsomal fraction.

  1966cited by this paper

• Comparison of Pharmacokinetics and Tissue Distribution Kinetics of Roxithromycin and Expression of CYP 3A1 between Pregnant Mice and Foetuses

  2017cites this paper
• Effects of silymarin on the pharmacokinetics of atorvastatin in diabetic rats

  2014cites this paper
• Time-dependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats

  2013cites this paper
• Comparison of the Contributions of Cytochromes P450 3A4 and 3A5 in Drug Oxidation Rates and Substrate Inhibition

  2010influential citation